» Articles » PMID: 2479170

HPV-18 Immortalization of Human Keratinocytes

Overview
Journal Virology
Specialty Microbiology
Date 1989 Nov 1
PMID 2479170
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

The oncogenic potential of human papillomavirus type 18 which is found in a significant number of cervical and penile cancer biopsies was tested in primary human keratinocytes derived from neonatal foreskin. Viral DNA and a gene for resistance to neomycin were introduced into these cells by calcium phosphate transfection. Selection of cells in G418 led to the isolation of resistant colonies which were propagated in culture. Four cell lines termed FE-A, FEH 18L, FEP18-5, and FEP18-11 have been maintained in culture for 1 1/2-2 years and were selected for further analysis. In all cases the viral DNA was integrated into the cellular genome and the early genes were transcribed, including RNA complementary to the E2, E6, and E7 open reading frames. Radioimmunoprecipitation showed that all cell lines synthesized the E6 and E7 proteins. However, none of the cell lines tested were tumorigenic. The differentiation capacity of these cells was analyzed by assessing their ability to proliferate clonally after exposure to 1.2 mM calcium chloride. All four cell lines were resistant to this stimulus and formed colonies upon return to regular growth medium whereas normal cells differentiated terminally. K6a and K14 keratin RNA expression was down-regulated in the HPV immortalized cell lines compared to primary human epithelial cells.

Citing Articles

Loss of keratin 14 expression from immortalized keratinocytes by promoter methylation.

Koh R, Szeverenyi I, Lunny D, Eng G, Lane E Exp Dermatol. 2024; 33(8):e15143.

PMID: 39073059 PMC: 11605495. DOI: 10.1111/exd.15143.


Combined treatment of the experimental human papilloma virus-16-positive cervical and head and neck cancers with cisplatin and radioimmunotherapy targeting viral E6 oncoprotein.

Harris M, Wang X, Jiang Z, Phaeton R, Koba W, Goldberg G Br J Cancer. 2013; 108(4):859-65.

PMID: 23385729 PMC: 3590678. DOI: 10.1038/bjc.2013.43.


Radioimmunotherapy of experimental head and neck squamous cell carcinoma (HNSCC) with E6-specific antibody using a novel HPV-16 positive HNSCC cell line.

Harris M, Wang X, Jiang Z, Goldberg G, Casadevall A, Dadachova E Head Neck Oncol. 2011; 3(1):9.

PMID: 21314983 PMC: 3046925. DOI: 10.1186/1758-3284-3-9.


Radioimmunotherapy with an antibody to the HPV16 E6 oncoprotein is effective in an experimental cervical tumor expressing low levels of E6.

Phaeton R, Harris M, Jiang Z, Wang X, Einstein M, Goldberg G Cancer Biol Ther. 2010; 10(10):1041-7.

PMID: 20861673 PMC: 3047096. DOI: 10.4161/cbt.10.10.13322.


Loss of estrogen receptor 1 enhances cervical cancer invasion.

Zhai Y, Bommer G, Feng Y, Wiese A, Fearon E, Cho K Am J Pathol. 2010; 177(2):884-95.

PMID: 20581058 PMC: 2913367. DOI: 10.2353/ajpath.2010.091166.